UBS Shifts to Bearish USD View, Eyes GBP Strengthby Mark Eisenberg 10.09.2024UBS advises selling USD gains, citing medium-term weakness, while GBP shows potential for strength. CHF remains supported.
Jefferies Upgrades Azelis & IMCD: Positive Specialty Chemicals Outlookby Mark Eisenberg 03.09.2024Jefferies upgrades Azelis and IMCD to 'buy' amid recovery in organic revenue and strategic updates from new CEOs.
Permira’s Insights on Tech Investment Trendsby Mark Eisenberg 27.08.2024Exploring Permira's strategies in tech investments, M&A, and IPOs amidst evolving market conditions.
Understanding the Hacker Threats in M&A Dealsby Lilu Anderson 23.08.2024M&A transactions are prime targets for hackers due to digital presence and financial gains.
Why Cybersecurity Stocks Deserve Your Attentionby Lilu Anderson 22.08.2024Cybersecurity stocks are on the rise as global digital threats increase, with governments boosting spending to counter these risks.
AI in Cybersecurity Market Surges to $85.14B by 2030by Lilu Anderson 19.08.2024AI in cybersecurity market to hit $85.14 billion by 2030, growing at 24.6% CAGR, driven by advanced threat detection needs.
Plus500’s Strong Q2 and Bullish Forecast Boost Sharesby Mark Eisenberg 19.08.2024Plus500 shares rise after a strong Q2 report and bullish full-year forecast, indicating potential market outperformance.
GDI Reports 5% Revenue Growth in Q2 2024 Resultsby Mark Eisenberg 18.08.2024GDI's Q2 2024 results show a 5% revenue rise, driven by acquisitions, with stable EBITDA and strategic growth focus.
Afya Reports 14% Revenue Growth in Q2 2024 Earningsby Mark Eisenberg 18.08.2024Afya's Q2 2024 results show 14% revenue growth, strategic expansions, and a focus on M&A and sustainability.
Biotech Funding Steady: Investors Eye Late-Stage Assetsby Lilu Anderson 18.08.2024Biotech sees stable funding as 2024 venture capital and IPOs rise. Investors focus on late-stage assets amid economic challenges.